Why Private Investment Agreement Disclosure Schedules Matter

A private investment agreement typically includes several foundational sections that define the investment terms and the parties' respective rights and responsibilities. The agreement should specify the investment amount, the class or type of security being purchased (equity, debt, convertible instrument), the valuation or price per unit, and the timing and mechanics of capital deployment. It should also outline the investor's governance rights, such as board observation, information access, or approval thresholds for major corporate actions, as well as any liquidation preferences, anti-dilution protections, or redemption rights that apply to your investment.

Representations and warranties from the company form another critical layer. These are statements of fact about the company's financial condition, legal compliance, intellectual property ownership, and absence of undisclosed liabilities. If these representations prove false after closing, the investor may have a claim for breach of contract or indemnification. The agreement should also detail the conditions precedent to closing, such as completion of due diligence, third-party consents, or regulatory approvals, and specify what happens if those conditions are not satisfied.

Investment terms directly shape your financial exposure and recovery options if the company underperforms or fails. Liquidation preferences determine the order and amount of proceeds you receive in a sale or dissolution; a senior liquidation preference means you recover your capital before common shareholders receive anything. Anti-dilution provisions protect your ownership percentage if the company issues new shares at a lower price, though the specific mechanics (full ratchet, weighted average, or carve-outs) can significantly affect your stake.

Redemption or put rights allow you to force the company to repurchase your shares under specified conditions, such as after a certain holding period or if the company fails to achieve defined milestones. Drag-along rights obligate minority investors to sell their shares if a majority approves a sale, while tag-along rights let minority investors participate in a majority-approved sale on the same terms. Each of these provisions shifts risk and control between investor and company, so understanding which apply to your investment is essential before signing.

Private investment agreements carry several categories of legal risk that extend beyond simple market performance. Regulatory risk arises if the company operates in a sector subject to licensing, compliance, or oversight requirements; failure to maintain regulatory status can render the business inoperable or subject to penalties that impair your investment. Securities law risk may apply if the offering itself violates federal or state registration or exemption requirements, potentially exposing both the company and investors to enforcement action or rescission claims.

Tax risk is often underestimated in private investment contexts. The agreement may not clearly address how income, gains, or losses are allocated for federal and state tax purposes, or it may impose unexpected tax reporting obligations on the investor. A poorly structured investment vehicle or an ambiguous profit-sharing formula can create disputes over the investor's tax basis, holding period, or eligibility for favorable capital gains treatment. Consulting with a tax professional before signing is prudent, especially for substantial investments or complex structures.

New York courts have developed a substantial body of case law on private investment agreements, particularly in the context of venture capital and private equity transactions. New York courts generally enforce the plain language of investment agreements and are reluctant to rewrite terms on grounds of fairness or changed circumstances unless the agreement is genuinely ambiguous or a party can prove fraud, duress, or unconscionability. This means that if you sign an agreement with unfavorable terms or incomplete risk disclosures, a New York court may not rescue you from that bargain, even if the investment performs poorly.

When disputes arise, New York courts apply standard contract interpretation principles, looking first to the agreement's text, then to the parties' course of dealing and industry custom. If the agreement includes a choice-of-law clause naming New York law, New York courts will apply New York contract doctrine to resolve disputes over representations, warranties, indemnification, and remedies. Parties often include arbitration or mediation clauses in private investment agreements to avoid litigation; if your agreement includes such a clause, you may be required to pursue your claim through arbitration rather than court, which can affect your procedural rights and remedies.

The company issuing or managing the investment is generally required to disclose material facts that would affect a reasonable investor's decision to invest. Material facts include financial performance, existing debt or liabilities, pending litigation, regulatory investigations, key personnel risks, and competitive threats. The scope of disclosure is typically defined by the agreement itself; some agreements impose a general duty to disclose all material facts, while others limit disclosure to specific schedules or exhibits attached to the agreement.

If the company fails to disclose a material fact and you later discover the omission, you may have a claim for fraudulent inducement, negligent misrepresentation, or breach of the representations and warranties in the agreement. However, many private investment agreements include knowledge qualifiers (e.g., to the best of the company's knowledge) or carve-outs for facts disclosed in attached schedules, which can narrow the company's liability. Some agreements also include a no reliance clause stating that you are relying solely on your own due diligence and not on any representations outside the agreement; such clauses can limit your remedies if undisclosed facts emerge.

Disclosure schedules are exhibits attached to the agreement that list exceptions to the company's representations and warranties. For example, if the company represents that it has no pending litigation, the disclosure schedule might list three ongoing disputes. These schedules are considered part of the agreement and are binding on both parties. If the company fails to list a material exception on the schedule, that omission can constitute a breach of the representation, giving you a claim for indemnification or rescission.

In practice, disclosure schedules are often dense and technical; investors and their counsel must carefully review them during due diligence to identify red flags or ambiguities. A missing or vague disclosure schedule entry can become a major source of post-closing disputes. For instance, if the company discloses certain customer contracts without specificity, and you later discover that the company's largest customer has a termination right or reduced commitment, you may struggle to prove that the company breached its representation because the schedule arguably flagged the risk, albeit vaguely.

Due diligence is the investigative process you undertake before signing the agreement to verify the company's representations and assess investment risk. Effective due diligence includes reviewing audited or reviewed financial statements, tax returns, and management accounts; examining material contracts, including customer, supplier, and employment agreements; investigating regulatory compliance and licensing status; and assessing intellectual property ownership and any third-party claims. You should also interview key management and, if possible, speak with major customers or partners to validate the company's market position and growth trajectory.

During due diligence, preserve all documents, emails, presentations, and notes that inform your investment decision. These materials become critical evidence if a dispute arises later; they can show what you knew or should have known before signing, which affects your ability to claim that the company's representations were false or that material facts were omitted. If the company provides a data room or document portal, download and archive all materials before signing. If you receive verbal assurances or see presentations that conflict with the written agreement, document those communications in writing immediately so you have a record.

Engaging experienced counsel to review and negotiate the agreement before you sign is a prudent safeguard. Counsel can identify problematic terms, such as overly broad indemnification obligations, ambiguous representations, or one-sided dispute resolution mechanisms. An attorney can also flag gaps in disclosure schedules, negotiate carve-outs or knowledge qualifiers that protect you, and ensure that the agreement's remedies (indemnification caps, baskets, survival periods) are balanced and enforceable.